FDA Inspection 732159 — Sciregs
The FDA completed an inspection of Sciregs on Jun 17, 2011 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 17, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)